A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
Active, not recruiting · NCT06265428 · Registry updated 2025-10-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2025-10-20 | NCT06265428 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioNTech SE | 53 |
| DualityBio Inc. | 15 |
48 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 001 | Beijing | China | 1 |
| 002 | Shanghai | China | 1 |
| 003 | Xi’an | China | 1 |
| 004 | Nanjing | China | 1 |
| 005 | Zhengzhou | China | 1 |
| 006 | Zhengzhou | China | 1 |
| 007 | Chengdu | China | 1 |
| 008 | Changchun | China | 1 |
| 009 | Wuhan | China | 1 |
| 010 | Beijing | China | 1 |
| 011 | Wuhan | China | 1 |
| 012 | Linyi | China | 1 |
| 013 | Ürümqi | China | 1 |
| 014 | Nanchang | China | 1 |
| 015 | Bengbu | China | 1 |
| 016 | Hefei | China | 1 |
| 017 | Nanning | China | 1 |
| 018 | Luoyang | China | 1 |
| 019 | Hangzhou | China | 1 |
| 020 | Haerbin | China | 1 |
| 021 | Tianjin | China | 1 |
| 022 | Nanning | China | 1 |
| 023 | Guangzhou | China | 1 |
| 024 | Guangzhou | China | 1 |
| 025 | Hangzhou | China | 1 |